Ferreira Andrea C B, Gobara Satiko, Costa Silvia E, Sauaia Naim, Mamizuka Elsa M, van der Heijden Inneke M, Soares Robson E, Almeida Gisele D, Fontana Carlos, Levin Anna S
Hospital das Clínicas, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.
Infect Control Hosp Epidemiol. 2004 Oct;25(10):868-72. doi: 10.1086/502311.
To evaluate the emergence of resistance of Pseudomonas aeruginosa and Acinetobacter species to imipenem, ciprofloxacin, or both after the use of these drugs and to compare resistant with susceptible isolates by molecular typing.
Cohort study.
Burn intensive care unit (ICU) with 4 beds in a tertiary-care university hospital.
During 16 months, surveillance cultures were performed for all patients admitted to the ICU. Demographic information was obtained for each patient. Molecular typing was done by pulsed-field gel electrophoresis using restriction enzymes for 71 isolates of P. aeruginosa and Acinetobacter species.
Thirty-four patients were admitted and 22 were colonized by susceptible P. aeruginosa or Acinetobacter species before they used the antimicrobials. Nine (41%) of these patients had a resistant isolate after antimicrobial use: 5 had used imipenem alone, 1 had used ciprofloxacin, and 3 had used both drugs. The interval between isolation of the susceptible and resistant isolates ranged from 4 to 25 days, but was 10 or more days for 6 patients. Molecular typing revealed that susceptible and resistant isolates from each patient were different and that although there were no predominant clones among susceptible isolates, there was a predominant clone among resistant isolates of P. aeruginosa and of Acinetobacter.
Resistance was not due to the acquisition of resistance mechanisms by a previously susceptible strain, but rather to cross-transmission. Although various measures involving antimicrobial use have received great attention, it would seem that practices to prevent cross-transmission are more important in controlling resistance.
评估铜绿假单胞菌和不动杆菌属在使用亚胺培南、环丙沙星或两者后对这些药物产生耐药性的情况,并通过分子分型比较耐药菌株和敏感菌株。
队列研究。
一所三级大学医院中设有4张床位的烧伤重症监护病房(ICU)。
在16个月期间,对入住ICU的所有患者进行监测培养。获取每位患者的人口统计学信息。使用限制性内切酶通过脉冲场凝胶电泳对71株铜绿假单胞菌和不动杆菌属菌株进行分子分型。
34名患者入院,其中22名在使用抗菌药物前被敏感的铜绿假单胞菌或不动杆菌属菌株定植。这些患者中有9名(41%)在使用抗菌药物后出现了耐药菌株:5名仅使用了亚胺培南,1名使用了环丙沙星,3名同时使用了这两种药物。敏感菌株和耐药菌株分离之间的间隔时间为4至25天,但6名患者的间隔时间为10天或更长。分子分型显示,每位患者的敏感菌株和耐药菌株不同,并且尽管敏感菌株中没有优势克隆,但铜绿假单胞菌和不动杆菌属的耐药菌株中有一个优势克隆。
耐药性并非由于先前敏感菌株获得耐药机制所致,而是由于交叉传播。尽管涉及抗菌药物使用的各种措施备受关注,但似乎预防交叉传播的措施在控制耐药性方面更为重要。